DYANAVEL XR 15 MG TABLET
FDA nonproprietary name: amphetamine
For 30 tablets
Pharmacies pay
$444.19 filed
30 × $14.80648 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$515.82 estimated
$444.19 + $66.63 (15%) + $5.00 fee per fill = $515.82
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
DYANAVEL XR 15 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as amphetamine, under the trade name “DYANAVEL XR”.
FDA gives its dosage form as tablet, extended release and its route as oral.
The labeler, the company named on the label, is NextWave Pharmaceuticals, Inc.
FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 24478-0109-01.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $444.19 for 30 tablets (30 × $14.80648 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The NDC
- 24478-0109-01 · NextWave Pharmaceuticals, Inc · $14.80648 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
18 other products in the NADAC file share the FDA nonproprietary name amphetamine with DYANAVEL XR 15 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ADZENYS XR-ODT 3.1 MG TABLET | $19.20464 per EA filed | $16.14775 per EA filed |
| ADZENYS XR-ODT 6.3 MG TABLET | $19.20888 per EA filed | $16.14775 per EA filed |
| ADZENYS XR-ODT 9.4 MG TABLET | $19.18353 per EA filed | $16.14775 per EA filed |
| ADZENYS XR-ODT 12.5 MG TABLET | $19.20538 per EA filed | $16.14775 per EA filed |
| ADZENYS XR-ODT 15.7 MG TABLET | $19.16368 per EA filed | $16.14775 per EA filed |
| ADZENYS XR-ODT 18.8 MG TABLET | $19.21085 per EA filed | $16.14775 per EA filed |
| AMPHETAMINE ER 3.1 MG ODT | $15.84156 per EA filed | We don’t know yet |
| AMPHETAMINE ER 6.3 MG ODT | $16.07321 per EA filed | We don’t know yet |
| AMPHETAMINE ER 9.4 MG ODT | $16.21781 per EA filed | We don’t know yet |
| AMPHETAMINE ER 12.5 MG ODT | $15.96228 per EA filed | We don’t know yet |
| AMPHETAMINE ER 15.7 MG ODT | $15.92901 per EA filed | We don’t know yet |
| AMPHETAMINE ER 18.8 MG ODT | $15.61431 per EA filed | We don’t know yet |
| AMPHETAMINE SULFATE 5 MG TAB | $0.45734 per EA filed | $1.58404 per EA filed |
| AMPHETAMINE SULFATE 10 MG TAB | $0.44899 per EA filed | $1.58404 per EA filed |
| DYANAVEL XR 2.5 MG/ML SUSP | $2.75749 to $2.76739 per ML filed | We don’t know yet |
| DYANAVEL XR 5 MG TABLET | $7.8534 per EA filed | We don’t know yet |
| DYANAVEL XR 10 MG TABLET | $14.77832 per EA filed | We don’t know yet |
| DYANAVEL XR 15 MG TABLET this page | $14.80648 per EA filed | We don’t know yet |
| DYANAVEL XR 20 MG TABLET | $14.78945 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $14.80648 per EA filed.
Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 29 have a higher middle NADAC price and 174 a lower one. The one in the middle is LISDEXAMFETAMINE 20 MG TB CHEW, at $4.33791 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic class
Related in the same class
- METHYLPHENIDATE ER 10 MG TAB
- VYVANSE 10 MG CAPSULE
- DEXTROAMPHETAMINE 10 MG TAB
- BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE
- DEXMETHYLPHENIDATE ER 10 MG CP